<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>Chapter 22 Licensing of Wholesale Prescription Drug or Device Distributors | Library of Maryland Regulations</title>
    <link rel="shortcut icon" href="/us/md/exec/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/md/exec/comar/10.34.22/index.full.html" data-document="href"/>
    <meta itemprop="toc-json" content="/us/md/exec/comar/10.34.22/index.json" data-document="href"/>
    <meta itemprop="parent-doc-url" content="/us/md/exec/comar" data-document="href"/>
    <meta itemprop="order" content="|10|34|22|"/>
    <meta itemprop="doc-type" content="container" data-document=""/>
    <meta itemprop="doc-num" content="22"/>
    <meta itemprop="ref-doc" content="Code of Maryland Regulations" data-document=""/>
    <meta itemprop="ref-path" content="10|34|22" data-document=""/>
    <!--OpenGraph-->
    <meta property="og:url" content="http://regs.maryland.gov//us/md/exec/comar/10.34.22"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content="Chapter 22 Licensing of Wholesale Prescription Drug or Device Distributors | Library of Maryland Regulations"/>
    <meta property="og:image" content="http://regs.maryland.gov//us/md/exec/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#0078EF"/>
    <meta name="apple-mobile-web-app-title" content="Library of Maryland Regulations"/>
    <meta name="theme-color" content="#0078EF"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/md/exec/_document/v2/images/favicons/safari-pinned-tab.svg" color="#0078EF"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/md/exec/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/md/exec/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/md/exec/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/md/exec/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/public-sans/public-sans.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/merriweather/merriweather.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/roboto-mono/roboto-mono.css" type="text/css" rel="stylesheet" data-document=""/>
    <!--Document CSS-->
    <link href="/us/md/exec/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print" data-document=""/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js" data-document=""> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/md/exec/comar/10.34.22/index.full.html" as="fetch"/>
    <link rel="prefetch" href="/index.json" as="fetch"/>
    <link rel="prefetch" href="/us/md/exec/comar/10.34.22/index.json" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message"> </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__maryland-dsd">
      <header id="section__header" class="ns__document__maryland-dsd">
        <div id="section__header__inner" class="ns__document__maryland-dsd">
          <div id="area__logo" class="ns__document__maryland-dsd">
            <a href="/" class="logo" aria-label="Logo - Return to library home page">
              <img src="/us/md/exec/_document/v2/images/logo/logo.png" srcset="/us/md/exec/_document/v2/images/logo/logo.png 1x, /us/md/exec/_document/v2/images/logo/logo@2x.png 2x, /us/md/exec/_document/v2/images/logo/logo@3x.png 3x" alt="Library of Maryland Regulations logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__maryland-dsd">
            <div class="h__library-logotype"><span class="line1">Library of</span> <span class="line2">Maryland Regulations</span></div>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__maryland-dsd">
        <div id="section__content__inner" class="ns__document__maryland-dsd">
          <section id="area__breadcrumbs" class="ns__document__maryland-dsd" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="Library of Maryland Regulations">Library of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations" data-search-heading="" data-search-default="true" class="li__book-open">
                  <a href="/us/md/exec/comar" title="Code of Maryland Regulations">Code of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10" data-search-heading="">
                  <a href="/us/md/exec/comar/10" title="Title 10 MARYLAND DEPARTMENT OF HEALTH">Title 10 MARYLAND DEPARTMENT OF HEALTH</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|34" data-search-heading="">
                  <a href="/us/md/exec/comar/10.34" title="Subtitle 34 BOARD OF PHARMACY">Subtitle 34 BOARD OF PHARMACY</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|34|22" data-search-heading="">
                  <span title="Chapter 22 Licensing of Wholesale Prescription Drug or Device Distributors">Chapter 22 Licensing of Wholesale Prescription Drug or Device Distributors</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__maryland-dsd">
            <div class="h__document-title">Code of Maryland Regulations</div>
            <article class="content" role="document" data-ref-path="10|34|22">
              <div class="tuf-authenticate">
                <h1 class="h__toc" id="/us/md/exec/comar/10.34.22">Chapter 22 Licensing of Wholesale Prescription Drug or Device Distributors</h1>
                <section class="line-group annotations">
                  <h2>Administrative History</h2>
                  <p>Effective date: August 31, 1992 (19:17 Md. R. 1607)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.03#B" title="">Regulation .03B</a> amended effective November 7, 1994 (21:22 Md. R. 1877)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.04" title=".04 Personnel.">Regulation .04</a> amended effective November 7, 1994 (21:22 Md. R. 1877)</p>
                  <p>——————</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.01" title=".01 Scope.">.01</a> — <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.10" title=".10 Required Information and Procedures for Ceasing to Operate.">.10</a> repealed and new Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.01" title=".01 Scope.">.01</a> — <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.09" title=".09 Reinstatement.">.09</a> adopted effective March 28, 2005 (32:6 Md. R. 636)</p>
                  <p>——————</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.01" title=".01 Scope.">.01</a> — <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.09" title=".09 Reinstatement.">.09</a> repealed and new Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.01" title=".01 Scope.">.01</a> — <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.08" title=".08 Due Diligence.">.08</a> adopted effective April 7, 2008 (35:7 Md. R. 748)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.02#B" title="">Regulation .02B</a> amended as an emergency provision effective June 18, 2009 (36:15 Md. R. 1163); amended permanently effective October 5, 2009 (36:20 Md. R. 1529)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.02#B" title="">Regulation .02B</a> amended effective July 1, 2014 (41:10 Md. R. 561)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.03" title=".03 Minimum Application Requirements for Applicants Holding Product.">Regulation .03</a> amended effective July 1, 2014 (41:10 Md. R. 561)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.03#E" title="">Regulation .03E</a> amended as an emergency provision effective June 18, 2009 (36:15 Md. R. 1163); amended permanently effective October 5, 2009 (36:20 Md. R. 1529)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.03-1" title=".03-1 Minimum Application Requirements for Virtual Manufacturers.">Regulation .03-1</a> adopted effective July 1, 2014 (41:10 Md. R. 561)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.05#A" title="">Regulation .05A</a> amended effective July 1, 2014 (41:10 Md. R. 561)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.09" title=".09 Reinstatement.">Regulation .09</a> adopted effective July 1, 2014 (41:10 Md. R. 561)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.10" title=".10 Required Information and Procedures for Ceasing to Operate.">Regulation .10</a> adopted effective July 1, 2014 (41:10 Md. R. 561)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.11" title=".11 Relocation.">Regulation .11</a> adopted effective July 1, 2014 (41:10 Md. R. 561)</p>
                  <h2>Authority</h2>
                  <p>Health Occupations Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-205" title="">12-205</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-601" title="">12-601</a>, and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">12-6</a>C-01 — 12-6C-13, Annotated Code of Maryland</p>
                </section>
                <h2 id="/us/md/exec/comar/10.34.22.01" data-order="|10|34|22|.01|" data-ref-path="10|34|22|.01" class="h__section">.01 Scope.</h2>
                <p>This chapter applies to any person engaged in the wholesale distribution of prescription drugs or devices in Maryland.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.22.02" data-order="|10|34|22|.02|" data-ref-path="10|34|22|.02" class="h__section">.02 Definitions.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(1)">(1)</span> “ANDA” means an Abbreviated New Drug Application number and contains data that, when submitted to the U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research, Office of Generic Drugs, provides for the review and ultimate approval of a generic drug product.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(1-1)">(1-1)</span> "Authenticate" means to affirmatively verify, before any wholesale distribution of a prescription drug occurs, that each transaction listed on the pedigree for the prescription drug has occurred.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(2)">(2)</span> "Authorized distributor of record" means a wholesale distributor with whom a manufacturer has established an ongoing relationship to distribute the manufacturer's prescription drug.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(3)">(3)</span> "Blood" means whole blood collected from a single donor and processed either for transfusion or further manufacturing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(4)">(4)</span> "Blood component" means that part of blood separated by physical or mechanical means.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(5)">(5)</span> "Board" means the State Board of Pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(5-1)">(5-1)</span> “Cease to operate” means the date on which the last prescription drug or prescription device is distributed by the permit holder.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(5-2)">(5-2)</span> “Central repository” means the Criminal Justice Information System Central Repository of the Department of Public Safety and Correctional Services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(6)">(6)</span> "Co-licensed partner" means a person in a relationship in which two or more persons have the right to engage in the manufacturing or marketing of a prescription drug, consistent with the U.S. Food and Drug Administration's implementation of the Federal Prescription Drug Marketing Act.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(7)">(7)</span> "DEA" means the U. S. Drug Enforcement Administration.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(8)">(8)</span> "Designated representative" means an individual who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(8)(a)">(a)</span> Is designated by the wholesale distributor;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(8)(b)">(b)</span> Serves as the primary contact of the wholesale distributor with the Board; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(8)(c)">(c)</span> Is actively involved in, and aware of, the daily operation of the wholesale distributor.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(8-1)">(8-1)</span> “Designee” means a Board contracted or Board recognized entity.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(9)">(9)</span> "Drop shipment" means the sale of a prescription drug:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(9)(a)">(a)</span> To a wholesale distributor by:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(9)(a)(i)">(i)</span> The manufacturer of the prescription drug; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(9)(a)(ii)">(ii)</span> The manufacturer's co-licensed partner, third-party logistics provider, or manufacturer's exclusive distributor; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(9)(b)">(b)</span> Through which:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(9)(b)(i)">(i)</span> The wholesale distributor or a pharmacy warehouse takes title to, but not physical possession of, the prescription drug;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(9)(b)(ii)">(ii)</span> The wholesale distributor invoices the pharmacy, pharmacy warehouse, or other person authorized by law to dispense or administer the prescription drug to a patient; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(9)(b)(iii)">(iii)</span> The pharmacy, pharmacy warehouse, or other authorized person receives delivery of the prescription drug directly from the manufacturer, the manufacturer's third-party logistics provider, or the manufacturer's exclusive distributor.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(10)">(10)</span> "FDA" means the U. S. Food and Drug Administration.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(11)">(11)</span> "Gross receipts" means gross receipts from sales of prescription drugs and devices in the State.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(12)">(12)</span> Health Care Entity.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(12)(a)">(a)</span> "Health care entity" means a person that provides diagnostic, medical, surgical, or dental treatment, or chronic or rehabilitative care.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(12)(b)">(b)</span> "Health care entity" does not include a community pharmacy or a wholesale distributor.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(12)(c)">(c)</span> "Health care entity" may not simultaneously be a health care entity and a community pharmacy or wholesale distributor.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(12-1)">(12-1)</span> “Intracompany sales” means a:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(12-1)(a)">(a)</span> Transaction or transfer of prescription drugs between a division, subsidiary, parent, or affiliated or related company under common ownership and control of a corporate entity, other than a transaction or transfer of prescription drugs from a pharmacy to a wholesale distributor; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(12-1)(b)">(b)</span> Transaction or transfer of a co–licensed product between co–licensed partners.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(13)">(13)</span> "Manufacturer" means a person licensed or approved by the U.S. Food and Drug Administration to engage in the manufacture of prescription drugs or prescription devices, consistent with the definition of "Manufacturer" under the U.S. Food and Drug Administration's regulations and guidelines implementing the Prescription Drug Marketing Act.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(14)">(14)</span> "Manufacturer's exclusive distributor" means a person who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(14)(a)">(a)</span> Contracts with a manufacturer to provide or coordinate warehousing, distribution, or other services on behalf of the manufacturer; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(14)(b)">(b)</span> Takes title to the manufacturer's prescription drug, but does not have general responsibility to direct the sale or disposition of the manufacturer's prescription drug.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(14-1)">(14-1)</span> “NDA” means a New Drug Application number assigned by the FDA for drugs formally proposed to the FDA as a new pharmaceutical for sale and marketing in the U.S.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(15)">(15)</span> "Normal distribution channel" means a chain of custody for a prescription drug that, directly or by drop shipment, goes:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(15)(a)">(a)</span> From:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(15)(a)(i)">(i)</span> A manufacturer of the prescription drug; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(15)(a)(ii)">(ii)</span> The manufacturer's co-licensed partner, third-party logistics provider, or manufacturer's exclusive distributor; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(15)(b)">(b)</span> To:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(15)(b)(i)">(i)</span> A pharmacy or other designated person authorized by law to dispense or administer the prescription drug to a patient;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(15)(b)(ii)">(ii)</span> A wholesale distributor to a pharmacy or other designated person authorized by law to dispense or administer the prescription drug to a patient;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(15)(b)(iii)">(iii)</span> A wholesale distributor to a pharmacy warehouse to the pharmacy warehouse's intracompany pharmacy or other designated person authorized by law to dispense or administer the prescription drug to a patient;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(15)(b)(iv)">(iv)</span> A pharmacy warehouse to the pharmacy warehouse's intracompany pharmacy, or other designated person authorized by law to dispense or administer the prescription drug to a patient; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(15)(b)(v)">(v)</span> An authorized distributor of record to another authorized distributor of record solely for distribution to an office-based health care practitioner authorized by law to dispense or administer the prescription drug to a patient.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(16)">(16)</span> "Pedigree" means a document or electronic file containing information that records each wholesale distribution of a prescription drug.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(16-1)">(16-1)</span> “Pharmacy” means a pharmacy that has been issued a:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(16-1)(a)">(a)</span> Waiver pharmacy permit in accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.17" title="Chapter 17 Waiver of Full Service Requirements for Recognized Pharmaceutical Specialties">COMAR 10.34.17</a>; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(16-1)(b)">(b)</span> Full service pharmacy permit.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(17)">(17)</span> "Prescription device" means any device required by federal law or regulation to be dispensed only by a prescription.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(18)">(18)</span> Prescription Drug.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(18)(a)">(a)</span> "Prescription drug" means any drug required by federal law or regulation to be dispensed only by a prescription.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(18)(b)">(b)</span> "Prescription drug" includes:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(18)(b)(i)">(i)</span> A biological product; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(18)(b)(ii)">(ii)</span> Finished dosage forms and bulk drug substances subject to §503(b) of the Federal Food, Drug and Cosmetic Act.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(18)(c)">(c)</span> "Prescription drug" does not include blood and blood components intended for transfusion or biological products that are also medical devices.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(18-1)">(18-1)</span> “Reinstatement” means renewal of a wholesale distributor permit after the permit has expired.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(18-2)">(18-2)</span> “Renewal” means renewing a wholesale distributor permit before the date of expiration.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(19)">(19)</span> Repackage.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(19)(a)">(a)</span> "Repackage" means to repackage or otherwise change the container, wrapper, or labeling of a prescription drug to further the distribution of the prescription drug.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(19)(b)">(b)</span> "Repackage" does not include changes to a container, wrapper, or labeling of a prescription drug completed by the pharmacist responsible for dispensing the prescription drug to a patient.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(20)">(20)</span> "Repackager" means a person who repackages prescription drugs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(21)">(21)</span> "Third-party logistics provider" means a person who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(21)(a)">(a)</span> Contracts with a manufacturer to provide or coordinate warehousing, distribution, or other services on behalf of the manufacturer; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(21)(b)">(b)</span> Does not take title to the prescription drug, or have general responsibility to direct the prescription drug's sale or disposition.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(21-1)">(21-1)</span> “UDI” means a Unique Device Identification number that is created through a globally accepted device identification and coding standard that allows the unambiguous identification of a specific medical device.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(21-2)">(21-2)</span> Virtual Manufacturer.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(21-2)(a)">(a)</span> “Virtual Manufacturer” means an entity that engages in the manufacture of drug or device products for which it:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(21-2)(a)(i)">(i)</span> Owns the NDA or ANDA number, if a prescription drug;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(21-2)(a)(ii)">(ii)</span> Owns the UDI number, as available, for a prescription device;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(21-2)(a)(iii)">(iii)</span> Contracts with a contract manufacturing organization for the physical manufacture of the drug or device product;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(21-2)(a)(iv)">(iv)</span> Is not involved in the physical manufacture of the drug or device product; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(21-2)(a)(v)">(v)</span> At no time takes physical possession of, or stores, the drug or device product.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(21-2)(b)">(b)</span> “Virtual Manufacturer” may include entities that are identified as a broker, own-label distributor, sponsor manufacturer, private-label manufacturer, or contract manufacturer.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(22)">(22)</span> Wholesale Distribution.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(22)(a)">(a)</span> "Wholesale distribution" means the distribution of prescription drugs or prescription devices to persons other than a consumer or patient.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(22)(b)">(b)</span> "Wholesale distribution" does not include:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(22)(b)(i)">(i)</span> Intracompany sales;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(22)(b)(ii)">(ii)</span> The sale, purchase, distribution, trade, or transfer of a prescription drug or an offer to sell, purchase, distribute, trade, or transfer a prescription drug for emergency medical reasons which include transfers of prescription drugs or devices by a retail pharmacy to another retail pharmacy to alleviate a temporary shortage;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(22)(b)(iii)">(iii)</span> The distribution of samples of a prescription drug by a manufacturer's representative;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(22)(b)(iv)">(iv)</span> Prescription drug returns conducted by a hospital, health care entity, or charitable institution in accordance with 21 CFR §203.23, as amended;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(22)(b)(v)">(v)</span> The sale of minimal quantities of prescription drugs by retail pharmacies to licensed health care practitioners for office use;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(22)(b)(vi)">(vi)</span> The sale, purchase, or trade of a prescription drug, an offer to sell, purchase, or trade a prescription drug, or the dispensing of a prescription drug in accordance with a prescription;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(22)(b)(vii)">(vii)</span> The sale, transfer, merger, or consolidation of all or part of the business of a pharmacy to or with another pharmacy, whether accomplished as a purchase and sale of stock or business assets;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(22)(b)(viii)">(viii)</span> The sale, purchase, distribution, trade, or transfer of a prescription drug from one authorized distributor of record to one additional authorized distributor of record, if the manufacturer has stated in writing to the receiving authorized distributor of record that the manufacturer is unable to supply the prescription drug, and the supplying authorized distributor of record states in writing that the prescription drug being supplied had until that time been exclusively in the normal distribution channel;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(22)(b)(ix)">(ix)</span> The delivery of, or offer to deliver, a prescription drug by a common carrier solely in the common carrier's usual course of business of transporting prescription drugs, if the common carrier does not store, warehouse, or take legal ownership of the prescription drug; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(22)(b)(x)">(x)</span> The sale or transfer from a pharmacy or pharmacy warehouse of expired, damaged, returned, or recalled prescription drugs to the original wholesale distributor, the original manufacturer, or a third-party returns processor.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(23)">(23)</span> Wholesale Distributor.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(23)(a)">(a)</span> "Wholesale distributor" means a person that is engaged in the wholesale distribution of prescription drugs or prescription devices.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(23)(b)">(b)</span> "Wholesale distributor" includes:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(23)(b)(i)">(i)</span> A manufacturer;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(23)(b)(ii)">(ii)</span> A repackager;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(23)(b)(iii)">(iii)</span> An own-label distributor;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(23)(b)(iv)">(iv)</span> A private-label distributor;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(23)(b)(v)">(v)</span> A jobber;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(23)(b)(vi)">(vi)</span> A broker;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(23)(b)(vii)">(vii)</span> A warehouse, including a manufacturer's or distributor's warehouse;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(23)(b)(viii)">(viii)</span> A manufacturer's exclusive distributor, or an authorized distributor of record;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(23)(b)(ix)">(ix)</span> A drug wholesaler or distributor;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(23)(b)(x)">(x)</span> An independent wholesale drug trader;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(23)(b)(xi)">(xi)</span> A third-party logistics provider;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(23)(b)(xii)">(xii)</span> A pharmacy that conducts wholesale distribution, if the wholesale distribution business accounts for more than 5 percent of the pharmacy's annual sales; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(23)(b)(xiii)">(xiii)</span> A pharmacy warehouse that conducts wholesale distribution.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.22.03-1" data-order="|10|34|22|.03-1|" data-ref-path="10|34|22|.03-1" class="h__section">.03-1 Minimum Application Requirements for Virtual Manufacturers.</h2>
                <p>The information and qualification requirements for obtaining a permit under <a class="internal-link " href="/us/md/exec/comar/10.34.22.03" title=".03 Minimum Application Requirements for Applicants Holding Product.">Regulation .03 of this chapter</a>, beyond that required by federal law, do not apply to a virtual manufacturer that meets the following requirements:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03-1#A">A.</span> Provides a list of drug or device products it distributes;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03-1#B">B.</span> Provides a list of the NDA or ANDA numbers associated with each drug it distributes;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03-1#C">C.</span> Provides a list of the UDI numbers, as available, associated with each device it distributes;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03-1#D">D.</span> Provides the name and facility address of the contract manufacturer for each drug or device product it distributes;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03-1#E">E.</span> Provides verification of current FDA registration for each contract manufacturing facility listed;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03-1#F">F.</span> If the contract manufacturer distributes into this State, provides the wholesale distributor permit number for the contract manufacturer;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03-1#G">G.</span> If the contract manufacturer does not distribute into this State, provides name and Maryland’s wholesale distributor permit number for the entity that physically distributes the product into this State;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03-1#H">H.</span> Provides a statement affirming that the virtual manufacturer does not contract the manufacture or distribution for drugs or devices other than those for which it owns the NDA, ANDA, or UDI numbers;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03-1#I">I.</span> Provides an attestation by the owner of the virtual manufacturer that it does not hold product;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03-1#J">J.</span> Provides a copy of existing licensure from the state in which it is located, if applicable; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03-1#K">K.</span> Has valid federal licensure or registration, as verified by the Board.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.22.03" data-order="|10|34|22|.03|" data-ref-path="10|34|22|.03" class="h__section">.03 Minimum Application Requirements for Applicants Holding Product.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A">A.</span> The Board shall require the following minimum information from a wholesale distributor as part of an application for a permit and as part of a renewal of a permit:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(1)">(1)</span> The type of business form under which the applicant operates, such as partnership, corporation, or sole proprietorship;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)">(2)</span> The full name or names of the owner and the operator of the wholesale distributor applying for or renewing a permit, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(a)">(a)</span> For an individual, the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(a)(i)">(i)</span> Full name of the individual;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(a)(ii)">(ii)</span> Telephone number of the individual;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(a)(iii)">(iii)</span> Business address of the individual; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(a)(iv)">(iv)</span> Date of birth of the individual;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(b)">(b)</span> For a partnership, the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(b)(i)">(i)</span> Full name of each partner;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(b)(ii)">(ii)</span> Telephone number of the partnership;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(b)(iii)">(iii)</span> Address of each partner;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(b)(iv)">(iv)</span> Date of birth of each partner;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(b)(v)">(v)</span> Business address of the partnership; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(b)(vi)">(vi)</span> Federal employer identification number of the partnership;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(c)">(c)</span> For a publicly traded corporation, the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(c)(i)">(i)</span> Full name and title of each corporate officer and director;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(c)(ii)">(ii)</span> Telephone number of the publicly traded corporation;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(c)(iii)">(iii)</span> Business address of the corporation;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(c)(iv)">(iv)</span> Federal employer identification number of the corporation;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(c)(v)">(v)</span> Name of parent company or companies if applicable;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(c)(vi)">(vi)</span> Corporate names;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(c)(vii)">(vii)</span> Name of the state of incorporation; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(c)(viii)">(viii)</span> Name and address of the resident agent of the corporation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(d)">(d)</span> For a nonpublicly traded corporation, the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(d)(i)">(i)</span> Full name and title of each corporate officer and director;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(d)(ii)">(ii)</span> The telephone number of the nonpublicly traded corporation;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(d)(iii)">(iii)</span> Business address of the corporation;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(d)(iv)">(iv)</span> Federal employer identification number of the corporation;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(d)(v)">(v)</span> Name of parent company or companies if applicable;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(d)(vi)">(vi)</span> Corporate names;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(d)(vii)">(vii)</span> Full name and business address of shareholders of more than 10 percent of the corporation, including over-the-counter stock, unless the stock is traded on a major stock exchange;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(d)(viii)">(viii)</span> Name of the state of incorporation; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(d)(ix)">(ix)</span> Name and address of the resident agent of the corporation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(e)">(e)</span> For a sole proprietorship, the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(e)(i)">(i)</span> Full name of the sole proprietor;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(e)(ii)">(ii)</span> The telephone number of the sole proprietor;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(e)(iii)">(iii)</span> Full name of the business entity;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(e)(iv)">(iv)</span> Business address; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(e)(v)">(v)</span> Date of birth of the sole proprietor;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(f)">(f)</span> For a limited liability company, the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(f)(i)">(i)</span> Full name and business address of the limited liability company;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(f)(ii)">(ii)</span> Telephone number of the limited liability company;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(f)(iii)">(iii)</span> Full name of each member;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(f)(iv)">(iv)</span> Full name of each manager;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(f)(v)">(v)</span> Federal employer identification number of the limited liability company;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(f)(vi)">(vi)</span> Name of the state in which the limited liability company was organized; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(f)(vii)">(vii)</span> Name and address of the resident agent of the company;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(3)">(3)</span> Addresses, telephone numbers, and the names of contact persons for the facility used by the applicant for the storage, handling, and distribution of prescription drugs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(4)">(4)</span> All trade or business names used by the permit holder which may not be identical to the name used by another unrelated applicant in the State;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(5)">(5)</span> A list of federal and state licenses, registrations, or permits, including the license, registration, or permit numbers issued to the wholesale distributor by federal authority or another state that authorizes the wholesale distributor to purchase, possess, and distribute prescription drugs or devices;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(6)">(6)</span> A list of disciplinary actions by federal or state agencies against the wholesale distributor as well as any such actions against principals, owners, directors, or officers;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(7)">(7)</span> For the designated representative and the immediate supervisor of the designated representative at the applicant's place of business the following information:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(7)(a)">(a)</span> Names;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(7)(b)">(b)</span> Places of residence for the past 7 years;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(7)(c)">(c)</span> Dates and places of birth;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(7)(d)">(d)</span> The name and address of each business where the individual was employed during the past 7 years, and the individual's job title or office held at each business;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(7)(e)">(e)</span> A statement of whether, during the past 7 years, the individual has been the subject of any proceeding for the revocation of any professional or business license or any criminal violation and, if so, the nature and disposition of the proceeding;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(7)(f)">(f)</span> A statement of whether, during the past 7 years, the individual has been enjoined, either temporarily or permanently, by a court of competent jurisdiction from violating any federal or state law regulating the possession, control, or distribution of prescription drugs, together with details concerning the event;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(7)(g)">(g)</span> A description of any involvement, including any investments other than the ownership of stock in a publicly traded company or mutual fund, by the individual during the past 7 years, with any business that manufactures, administers, prescribes, distributes, or stores prescription drugs, and any lawsuits in which the business was named as a party;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(7)(h)">(h)</span> A description of any misdemeanor or felony offense of which the individual, as an adult, was found guilty, regardless of whether adjudication of the guilt was withheld or whether the individual pled guilty or nolo contendere;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(7)(i)">(i)</span> If the individual indicates that a criminal conviction is under appeal and submits a copy of the notice of appeal, within 15 days after the disposition of the appeal, a copy of the final written order of disposition; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(7)(j)">(j)</span> A photograph of the individual taken in the previous 180 days;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(8)">(8)</span> A full description of the facility and warehouse including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(8)(a)">(a)</span> Square footage;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(8)(b)">(b)</span> Security and alarm system descriptions;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(8)(c)">(c)</span> Terms of lease or ownership;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(8)(d)">(d)</span> Address; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(8)(e)">(e)</span> Description of temperature and humidity controls;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(9)">(9)</span> Written evidence that the wholesale distributor has obtained general and product liability insurance;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(10)">(10)</span> A description of the wholesale distributor's import and export activities; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(11)">(11)</span> Other relevant information that the Board may require.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#B">B.</span> Criminal Background Check Requirements for an Applicant Located in this State. The Board shall require the designated representative and the immediate supervisor of the designated representative at the applicant's place of business as part of the application for a permit to submit to the Central Repository and the Federal Bureau of Investigation:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#B(1)">(1)</span> Electronically or digitally captured fingerprints at approved electronic fingerprint locations approved by the Director of the Central Repository;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#B(2)">(2)</span> The fee authorized under the <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcp&amp;section=10-221" title="">Criminal Procedure Article, §10-221(b)(7), Annotated Code of Maryland</a>, for access to State criminal history records; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#B(3)">(3)</span> The processing fee required by the Federal Bureau of Investigation for a national criminal history records check.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#B-1">B-1.</span> Criminal Background Check Requirements for an Applicant Located Outside this State.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#B-1(1)">(1)</span> The Board shall require the designated representative and the immediate supervisor of the designated representative at the applicant's place of business as part of the application for a permit to submit to a criminal history records check by the applicant’s state of residence, in accordance with the laws of the applicant’s state of residence.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#B-1(2)">(2)</span> The criminal history records check shall consist of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#B-1(2)(a)">(a)</span> A state criminal history records check for the applicant’s state of residence; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#B-1(2)(b)">(b)</span> A national criminal history records check.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#B-1(3)">(3)</span> The designated representative and the immediate supervisor of the designated representative of an applicant shall request the appropriate entity in the applicant’s state of residence to forward the results of the criminal history records check to the Board and the applicant.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#B-1(4)">(4)</span> If the appropriate entity in the applicant’s state of residence is unable to forward the results of the criminal history records check, then the designated representative and the immediate supervisor of the designated representative of an applicant shall ensure that the results of the criminal history records check are forwarded to the Board in a manner approved by the Board.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#C">C.</span> The information required under <a class="internal-link " href="/us/md/exec/comar/10.34.22.03#A" title="">§A of this regulation</a> shall be provided under oath.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D">D.</span> The Board may not issue an initial or renewal wholesale distributor permit to an applicant unless the Board or its designee:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(1)">(1)</span> If the applicant holds prescription drugs or devices, conducts a physical inspection of the applicant's place of business, including any facility of the applicant;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(2)">(2)</span> Finds that the place of business and facility, if any, meets the Board's requirements;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(3)">(3)</span> Determines that the designated representative of the applicant meets the following qualifications:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(3)(a)">(a)</span> Is 21 years old or older;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(3)(b)">(b)</span> Has been employed full time for at least 3 years in a pharmacy or with a wholesale distributor in a capacity related to the dispensing and distribution of, and record keeping relating to, prescription drugs;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(3)(c)">(c)</span> Is employed by the applicant full time in a managerial level position;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(3)(d)">(d)</span> Is actively involved in, and aware of, the daily operation of the wholesale distributor;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(3)(e)">(e)</span> Is physically present, except for an authorized absence such as sick leave or vacation leave, at the facility of the applicant during regular business hours;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(3)(f)">(f)</span> Is serving as a designated representative for only one applicant at a time, or for two or more wholesale distributors who are located in the same facility and are members of an affiliated group, as defined in §1504 of the Internal Revenue Code;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(3)(g)">(g)</span> Does not have any convictions for a violation of any federal, State, or local laws relating to wholesale or retail prescription drug distribution or distribution of controlled substances; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(3)(h)">(h)</span> Does not have any convictions for a felony under federal, State, or local laws; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(4)">(4)</span> Determines that the immediate supervisor of the designated representative of the applicant meets the following qualifications:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(4)(a)">(a)</span> Is 21 years old or older;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(4)(b)">(b)</span> Has been employed full time for at least 3 years in a pharmacy or with a wholesale distributor in a capacity related to the dispensing and distribution of, and record keeping relating to, prescription drugs;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(4)(c)">(c)</span> Is employed by the applicant full time in a managerial level position;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(4)(d)">(d)</span> Is actively involved in, and aware of, the daily operation of the wholesale distributor;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(4)(e)">(e)</span> Does not have any convictions for a violation of any federal, state, or local laws relating to wholesale or retail prescription drug distribution, or distribution of controlled substances; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(4)(f)">(f)</span> Does not have any convictions for a felony under federal, state, or local laws.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#E">E.</span> Surety Bond.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#E(1)">(1)</span> An applicant for a wholesale distributor permit shall submit a surety bond or other equivalent means of security acceptable to the State such as an irrevocable letter of credit, or a deposit in a trust account or financial institution, payable to the State Board of Pharmacy to be deposited into an account established by the State under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">Health Occupations Article, §12-6</a>C-05(f)(7), Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#E(2)">(2)</span> The surety bond, or other security, shall be in the amount of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#E(2)(a)">(a)</span> $100,000, if the annual gross receipts of the applicant for the previous tax year are $10,000,000 or more; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#E(2)(b)">(b)</span> $50,000, if the annual gross receipts of the applicant for the previous tax year are less than $10,000,000.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#E(3)">(3)</span> An applicant shall submit the following documentation to verify the applicant's annual gross receipts in the State are less than $10,000,000 for the previous tax year:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#E(3)(a)">(a)</span> A federal tax return; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#E(3)(b)">(b)</span> An annual sales report specifying the sales of prescription drugs and devices in the State audited by a certified public accountant.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#E(4)">(4)</span> A surety bond is not required for a pharmacy warehouse that is not engaged in wholesale distribution.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#E(5)">(5)</span> An applicant shall obtain a surety bond for each facility.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#E(6)">(6)</span> A single surety bond may cover all facilities operated by the applicant within this State.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#F">F.</span> If a wholesale distributor distributes prescription drugs or prescription devices from more than one facility, the wholesale distributor shall obtain a permit for each facility.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#G">G.</span> The Board shall notify the applicant of the Board's acceptance or rejection of the application within 30 days after the date the Board receives a completed application, including the results of all required criminal history records checks.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#H">H.</span> The applicant shall pay to the Board an application fee set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.09.02" title=".02 Fees.">COMAR 10.34.09.02</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#I">I.</span> The wholesale distributor shall provide changes in information provided pursuant to <a class="internal-link " href="/us/md/exec/comar/10.34.22.03" title=".03 Minimum Application Requirements for Applicants Holding Product.">Regulation .03 of this chapter</a> to the Board within 30 days of the effective date of the change.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#J">J.</span> Information and qualification requirements for obtaining a permit under this regulation, beyond that required by federal law, does not apply to a manufacturer who distributes its own prescription:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#J(1)">(1)</span> Drugs approved by the U.S. Food and Drug Administration; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#J(2)">(2)</span> Devices that are approved or authorized by the U.S. Food and Drug Administration.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.22.04" data-order="|10|34|22|.04|" data-ref-path="10|34|22|.04" class="h__section">.04 Personnel.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.04#A">A.</span> The permit holder shall affirm in the initial application and subsequent renewal applications that personnel employed in wholesale distribution have appropriate education and experience to assume responsibilities related to compliance with State licensing requirements.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.04#B">B.</span> Registered Agent.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.04#B(1)">(1)</span> Each licensed wholesale distributor located outside of this State that wholesale distributes prescription drugs or devices in this State shall designate a registered agent in this State for service of process.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.04#B(2)">(2)</span> If any wholesale distributor is not licensed in this State, service on the Director of the State Department of Assessments and Taxation only shall be sufficient service.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.04#C">C.</span> Requirements and Responsibilities of the Designated Representative.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.04#C(1)">(1)</span> The designated representative shall be aware of, and knowledgeable about, all policies and procedures pertaining to the operations of the wholesale distributor, including applicable State and federal laws.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.04#C(2)">(2)</span> The designated representative shall have documented training sufficient to ensure that operations of the wholesale distributor are in compliance with applicable State and federal laws and are provided by qualified in-house specialists, outside counsel, or consulting specialists with capabilities to help ensure compliance with all applicable State and federal laws and regulations.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.04#C(3)">(3)</span> The designated representative shall maintain current working knowledge of the requirements for wholesale distributor and assure ongoing training for personnel to ensure compliance.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.04#C(4)">(4)</span> The designated representative shall be responsible for all record keeping requirements and make all records available for inspection.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.22.05" data-order="|10|34|22|.05|" data-ref-path="10|34|22|.05" class="h__section">.05 Violations and Penalties.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A">A.</span> After a hearing held under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-601" title="">Health Occupations Article, §12-601, Annotated Code of Maryland</a>, the Board may deny, suspend, revoke, or place on probation a permit holder, reprimand a permit holder, or impose a fine if the permit holder:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(1)">(1)</span> Is convicted of, or pleads guilty or nolo contendere to, violations of federal, State, or local drug or device laws or regulations;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(2)">(2)</span> Is convicted of, or pleads guilty or nolo contendere to, a felony or to a crime involving moral turpitude, whether or not any appeal or other proceeding is pending to have the conviction or plea set aside;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)">(3)</span> Commits any of the following acts:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(a)">(a)</span> Obtains or attempts to obtain a permit by:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(a)(i)">(i)</span> Providing false information to the Board; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(a)(ii)">(ii)</span> Other fraudulent or deceptive means;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(b)">(b)</span> Fails to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(b)(i)">(i)</span> Establish or maintain inventories, records, or written policies and procedures as required by <a class="internal-link " href="/us/md/exec/comar/10.34.22.07" title=".07 Minimum Requirements for Maintenance of Prescription Drug or Device Distribution Records.">Regulation .07 of this chapter</a>;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(b)(ii)">(ii)</span> Register with the Maryland Division of Drug Control, and with the U.S. Drug Enforcement Agency, as required by <a class="internal-link " href="/us/md/exec/comar/10.34.22.07#D" title="">Regulation .07D of this chapter</a>; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(b)(iii)">(iii)</span> Permit the Board, the Maryland Division of Drug Control, the U.S. Drug Enforcement Agency, or other authorized federal, State, or local law enforcement officials showing proper identification, to enter, inspect, copy records, or audit as required by <a class="internal-link " href="/us/md/exec/comar/10.34.22.07#D" title="">Regulation .07D of this chapter</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(c)">(c)</span> Willfully makes or maintains false inventories or records;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(d)">(d)</span> Violates a provision of, or regulation promulgated under, <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 12, Annotated Code of Maryland</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(e)">(e)</span> Manufactures, repackages, sells, delivers, or holds or offers for sale any prescription drug or device that is adulterated, misbranded, counterfeit, suspected of being counterfeit, or has otherwise been rendered unfit for distribution or wholesale distribution;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(f)">(f)</span> Adulterates, misbrands, or counterfeits prescription drugs or devices;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(g)">(g)</span> Receives prescription drugs or devices that are adulterated, misbranded, stolen, obtained by fraud or deceit, counterfeit, or suspected of being counterfeit, or delivers or proffers delivery of such prescription drug or device for pay or otherwise;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(h)">(h)</span> Alters, mutilates, destroys, obliterates, or removes the whole or any part of the product labeling of a prescription drug or device, or commits any other act with respect to a prescription drug or device that results in the prescription drug or device being misbranded;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(i)">(i)</span> Forges, counterfeits, simulates, or falsely represents prescription drugs or devices without the authority of the manufacturer, or uses any mark, stamp, tag, label, or other identification device without the authorization of the manufacturer;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(j)">(j)</span> Purchases or receives a prescription drug or device from a person who is not licensed to wholesale distribute prescription drugs or devices to that purchaser or recipient;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(k)">(k)</span> Sells or transfers a prescription drug or device to a person who is not legally authorized to receive a prescription drug or device;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(l)">(l)</span> Provides the Board, its representatives, or federal or State officials with false or fraudulent records, or makes false or fraudulent statements regarding any matter within the provisions of these regulations;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(m)">(m)</span> Wholesale distributes prescription drugs or devices that were:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(m)(i)">(i)</span> Purchased by a public or private hospital, or other health care entity;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(m)(ii)">(ii)</span> Donated or supplied at a reduced price to a charitable organization;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(m)(iii)">(iii)</span> Stolen or obtained by fraud or deceit; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(m)(iv)">(iv)</span> Donated to a drop-off site or repository under the Prescription Drug Repository Program set forth in Health-General Article, Title 15, Subtitle 6, Annotated Code of Maryland;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(n)">(n)</span> Fails to obtain a license, or operates without a valid license when a license is required;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(o)">(o)</span> Obtains, or attempts to obtain, a prescription drug or device by fraud, deceit, misrepresentation, or engages in misrepresentation or fraud in the distribution or wholesale distribution of a prescription drug or device;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(p)">(p)</span> Distributes a prescription drug or device to a consumer or patient;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(q)">(q)</span> Fails to obtain, authenticate, or pass on a pedigree when required under these regulations;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(r)">(r)</span> Receives a prescription drug pursuant to a wholesale distribution without first receiving a pedigree, when required, that was attested to as accurate and complete by the wholesale distributor;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(s)">(s)</span> Distributes or wholesale distributes a prescription drug or device that was previously dispensed by a pharmacy or distributed by a practitioner;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(t)">(t)</span> Fails to report prohibited acts as listed in these regulations;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(u)">(u)</span> Fails to exercise due diligence as provided in <a class="internal-link " href="/us/md/exec/comar/10.34.22.08" title=".08 Due Diligence.">Regulation .08 of this chapter</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(v)">(v)</span> Otherwise conducts the wholesale distribution of prescription drugs or devices in a manner not in accordance with the law;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(w)">(w)</span> Accepts payment or credit for the sale of prescription drugs in violation of <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">Health Occupations Article, §12-6</a>C-09(d), Annotated Code of Maryland; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(x)">(x)</span> If the requirements of <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">Health Occupations Article, §12-6</a>C-09(a), Annotated Code of Maryland, are applicable and are not met, the purchasing or otherwise receiving a prescription drug from a pharmacy; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(4)">(4)</span> Is disciplined by a licensing or disciplinary authority of any state or country, or disciplined by a court of any state or country, for an act that would constitute a ground for Board action against a wholesale distributor permit holder under §A or B of this regulation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#B">B.</span> Acts prohibited under this regulation do not include a prescription drug manufacturer, or agent of a prescription drug manufacturer, obtaining or attempting to obtain a prescription drug for the sole purpose of testing the prescription drug for authenticity.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.22.06" data-order="|10|34|22|.06|" data-ref-path="10|34|22|.06" class="h__section">.06 Minimum Requirements for the Storage and Handling of Prescription Drugs or Devices.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A">A.</span> Facilities. Facilities at which prescription drugs or devices are stored, warehoused, handled, held, offered, marketed, or displayed shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(1)">(1)</span> Be of suitable size and construction to facilitate:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(1)(a)">(a)</span> Cleaning;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(1)(b)">(b)</span> Maintenance; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(1)(c)">(c)</span> Proper operations;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(2)">(2)</span> Have storage areas designed to provide adequate:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(2)(a)">(a)</span> Equipment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(2)(b)">(b)</span> Humidity control;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(2)(c)">(c)</span> Lighting;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(2)(d)">(d)</span> Sanitation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(2)(e)">(e)</span> Security conditions;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(2)(f)">(f)</span> Space;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(2)(g)">(g)</span> Temperature; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(2)(h)">(h)</span> Ventilation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(3)">(3)</span> Have a quarantine area for storage of prescription drugs or devices that are:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(3)(a)">(a)</span> Adulterated;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(3)(b)">(b)</span> Damaged;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(3)(c)">(c)</span> Deteriorated;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(3)(d)">(d)</span> In immediate or sealed secondary containers that have been opened;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(3)(e)">(e)</span> Misbranded; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(3)(f)">(f)</span> Outdated;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(4)">(4)</span> Be maintained in a clean and orderly condition; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(5)">(5)</span> Be free from infestation by insects, rodents, birds, or vermin.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#B">B.</span> Security. A facility:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#B(1)">(1)</span> Used for wholesale distribution shall be secure from unauthorized entry as follows:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#B(1)(a)">(a)</span> Access from outside the premises shall be:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#B(1)(a)(i)">(i)</span> Kept to a minimum; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#B(1)(a)(ii)">(ii)</span> Well controlled;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#B(1)(b)">(b)</span> The outside perimeter of the premises shall be well lit; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#B(1)(c)">(c)</span> Entry into areas where prescription drugs or devices are held shall be limited to authorized personnel;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#B(2)">(2)</span> Shall be equipped with:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#B(2)(a)">(a)</span> An alarm system to detect entry after hours;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#B(2)(b)">(b)</span> A security system that provides protection against theft and diversion;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#B(2)(c)">(c)</span> Appropriate software to facilitate the identification of evidence of tampering with computers or electronic records;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#B(2)(d)">(d)</span> An inventory management and control system that protects against, detects, and documents any instances of theft, diversion, or counterfeiting;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#B(2)(e)">(e)</span> A security system to protect the integrity and confidentiality of data and documents;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#B(2)(f)">(f)</span> Video monitoring of all entrances and exits, or alternate acceptable security; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#B(2)(g)">(g)</span> A means to make the data and documentation required under this section readily available to the Board, an agent of the Board, or federal and other State law enforcement officials.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#C">C.</span> Storage.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#C(1)">(1)</span> A wholesale distributor shall store a prescription drug or device at appropriate temperatures and under appropriate conditions in accordance with requirements:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#C(1)(a)">(a)</span> If any, of the labeling of the drug or device; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#C(1)(b)">(b)</span> Set forth in the current edition of an official compendium, such as the United States Pharmacopeia/National Formulary (USP/NF), under 21 CFR §205.50(c), as amended.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#C(2)">(2)</span> If no storage requirements are established for a prescription drug or device, the drug or device shall be held at a controlled room temperature, as defined in an official compendium as set forth in <a class="internal-link " href="/us/md/exec/comar/10.34.22.06#C(1)(b)" title="">§C(1)(b) of this regulation</a> to help assure that its identity, strength, quality, and purity are not adversely affected.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#C(3)">(3)</span> A wholesale distributor shall use appropriate manual, electromechanical, or electronic temperature and humidity recording equipment, devices, and logs to document proper storage of prescription drugs or devices.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#C(4)">(4)</span> A wholesale distributor shall follow the record-keeping requirements in <a class="internal-link " href="/us/md/exec/comar/10.34.22.07" title=".07 Minimum Requirements for Maintenance of Prescription Drug or Device Distribution Records.">Regulation .07 of this chapter</a> for stored prescription drugs or devices.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#D">D.</span> Examination of Materials.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#D(1)">(1)</span> Upon receipt, a wholesale distributor shall visually examine each outside shipping container for identity and to prevent the acceptance of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#D(1)(a)">(a)</span> Contaminated prescription drugs or devices; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#D(1)(b)">(b)</span> Prescription drugs or devices that are otherwise unfit for distribution.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#D(2)">(2)</span> The examination required under <a class="internal-link " href="/us/md/exec/comar/10.34.22.06#D(1)" title="">§D(1) of this regulation</a> shall be adequate to reveal container damage that would suggest possible contamination or other damage to the contents.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#D(3)">(3)</span> A wholesale distributor shall carefully inspect each outgoing shipment:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#D(3)(a)">(a)</span> For identity of the prescription drug or device product; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#D(3)(b)">(b)</span> To ensure that there is no delivery of a prescription drug or device that has been damaged in storage or held under improper conditions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#D(4)">(4)</span> A wholesale distributor shall follow the record-keeping requirements in <a class="internal-link " href="/us/md/exec/comar/10.34.22.07" title=".07 Minimum Requirements for Maintenance of Prescription Drug or Device Distribution Records.">Regulation .07 of this chapter</a> for incoming and outgoing prescription drugs or devices.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#E">E.</span> Returned, Damaged, and Outdated Prescription Drugs or Devices.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#E(1)">(1)</span> A wholesale distributor shall quarantine and physically separate prescription drugs or devices that are outdated, damaged, deteriorated, misbranded, or adulterated from other prescription drugs or devices until the quarantined and separated drugs or devices are destroyed or returned to their supplier for proper disposal.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#E(2)">(2)</span> The wholesale distributor shall identify, mark, quarantine, and physically separate from other prescription drugs or devices those prescription drugs or devices whose immediate or sealed outer or sealed secondary containers have been opened or used, until the drugs or devices are either destroyed or returned to their supplier for proper disposal.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#E(3)">(3)</span> Prescription Drugs.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#E(3)(a)">(a)</span> If the conditions under which a prescription drug has been returned cast doubt on the prescription drug's safety, identity, strength, quality, or purity, then the wholesale distributor shall destroy or return the prescription drug to the supplier, unless examination, testing, or other investigation proves that the prescription drug meets appropriate standards of safety, identity, strength, quality, and purity.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#E(3)(b)">(b)</span> In determining whether the conditions under which a prescription drug has been returned cast doubt on the prescription drug's safety, identity, strength, quality, or purity, the wholesale distributor shall consider, at a minimum, the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#E(3)(b)(i)">(i)</span> Conditions under which the prescription drug has been held, stored, or shipped before or during its return; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#E(3)(b)(ii)">(ii)</span> Condition of the prescription drug and its container, carton, or labeling, as a result of storage or shipping.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#E(4)">(4)</span> Prescription Devices.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#E(4)(a)">(a)</span> If the conditions under which a prescription device has been returned cast doubt on the prescription device's safety, identity, or quality, then the wholesale distributor shall destroy or return the prescription device to the supplier, unless examination, testing, or other investigation proves that the prescription device meets appropriate standards of safety, identity, strength, and quality.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#E(4)(b)">(b)</span> In determining whether the conditions under which a prescription device has been returned cast doubt on the prescription device's safety, identity, or quality, the wholesale distributor shall consider, among other things, the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#E(4)(b)(i)">(i)</span> Conditions under which the prescription device has been held, stored, or shipped before or during its return; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#E(4)(b)(ii)">(ii)</span> Condition of the prescription device and its container, carton, or labeling, as a result of storage or shipping.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#E(5)">(5)</span> A wholesale distributor shall follow the record-keeping requirements in <a class="internal-link " href="/us/md/exec/comar/10.34.22.07" title=".07 Minimum Requirements for Maintenance of Prescription Drug or Device Distribution Records.">Regulation .07 of this chapter</a> for outdated, damaged, deteriorated, misbranded, or adulterated prescription drugs or devices.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.22.07" data-order="|10|34|22|.07|" data-ref-path="10|34|22|.07" class="h__section">.07 Minimum Requirements for Maintenance of Prescription Drug or Device Distribution Records.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A">A.</span> Record Keeping.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(1)">(1)</span> A wholesale distributor shall establish and maintain inventories and records of transactions regarding the receipt and distribution or other disposition of prescription drugs or devices.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(2)">(2)</span> The records required under <a class="internal-link " href="/us/md/exec/comar/10.34.22.07#A(1)" title="">§A(1) of this regulation</a> shall include the following information:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(2)(a)">(a)</span> The source of the prescription drugs or devices, including the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(2)(a)(i)">(i)</span> Name and principal address of the seller or transferor; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(2)(a)(ii)">(ii)</span> Address of the location from which the prescription drugs or devices were shipped;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(2)(b)">(b)</span> The identity and quantity of the prescription drugs or devices received and distributed or disposed of;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(2)(c)">(c)</span> The dates of receipt and distribution or other disposition of the prescription drugs or devices; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(2)(d)">(d)</span> The pedigrees, if required by <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">Health Occupations Article, §12-6</a>C-10, Annotated Code of Maryland, for prescription drugs that are wholesale distributed outside the normal distribution channel.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(3)">(3)</span> The wholesale distributor shall make available inventories and records for inspection and copying by authorized federal, State, or local law enforcement agency officials for a period of 3 years after their date of creation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(4)">(4)</span> The wholesale distributor shall keep the records described in this regulation readily available for inspection by authorized federal, State, or local law enforcement agency officials during the retention period, either:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(4)(a)">(a)</span> At the inspection site; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(4)(b)">(b)</span> So as to be immediately retrievable by computer or other electronic means.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(5)">(5)</span> Within 5 working days of a request by an authorized official of a federal, State, or local law enforcement agency, the wholesale distributor shall make available for inspection records kept at a central location apart from the inspection site and not electronically retrievable.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(6)">(6)</span> Facilities shall establish and maintain procedures for reporting counterfeit and contraband or suspected counterfeit and contraband drugs or devices or counterfeiting and contraband or suspected counterfeiting and contraband activities to the Board and the FDA.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(7)">(7)</span> Wholesale distributors shall maintain a system for the mandatory reporting of significant inventory losses of prescription drugs and devices where it is known or suspected that diversion is occurring to the Board, the FDA, and, where applicable, to the DEA.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(8)">(8)</span> Wholesale distributors shall consider the following factors when determining if there has been a significant inventory loss:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(8)(a)">(a)</span> The schedule of the missing items;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(8)(b)">(b)</span> The abuse or misuse potential of the missing items;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(8)(c)">(c)</span> The abuse or misuse potential in the wholesale distributor's area of the missing substance;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(8)(d)">(d)</span> The quantity missing in relation to the total quantity purchased (one tablet vs. one bottle or container);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(8)(e)">(e)</span> Whether this is the first time a potentially significant inventory loss has occurred;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(8)(f)">(f)</span> Whether this loss was reported to local law enforcement authorities; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(8)(g)">(g)</span> Whether there is a significant resale value of the missing items.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B">B.</span> Written Policies and Procedures.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(1)">(1)</span> A wholesale distributor shall establish, maintain, and adhere to written policies and procedures which shall be followed for:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(1)(a)">(a)</span> The receipt, security, storage, inventory, and distribution of prescription drugs or devices;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(1)(b)">(b)</span> Identifying, recording, and reporting losses or thefts; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(1)(c)">(c)</span> Correcting errors and inaccuracies in inventories.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)">(2)</span> A wholesale distributor shall include in the written policies and procedures the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)(a)">(a)</span> A procedure by which the oldest approved and unexpired stock of a prescription drug or device is distributed first;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)(b)">(b)</span> Procedures to be followed for adequate handling of a recall and withdrawal of a prescription drug or device due to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)(b)(i)">(i)</span> An action initiated at the request of the United States Food and Drug Administration or other federal, State, or local law enforcement or other government agency, including the Maryland Division of Drug Control;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)(b)(ii)">(ii)</span> A voluntary action by the manufacturer to remove a defective or potentially defective drug or device from the market; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)(b)(iii)">(iii)</span> An action undertaken to promote public health and safety by replacing existing merchandise with an improved product or new package design;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)(c)">(c)</span> A procedure to ensure that the wholesale distributor is prepared for, protected against, and is able to handle a crisis that affects security or operation of a facility if any of the following situations occurs:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)(c)(i)">(i)</span> Strike;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)(c)(ii)">(ii)</span> Fire;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)(c)(iii)">(iii)</span> Flood;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)(c)(iv)">(iv)</span> Catastrophic health emergency as defined in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gps&amp;section=14-3" title="">Public Safety Article, §14-3</a>A-01, Annotated Code of Maryland;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)(c)(v)">(v)</span> Terrorist activities;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)(c)(vi)">(vi)</span> Other natural disaster; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)(c)(vii)">(vii)</span> Other situations of local, State, or national emergency;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)(d)">(d)</span> A procedure to ensure that an outdated prescription drug or device is segregated from other drugs or devices and either returned to the manufacturer or destroyed;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)(e)">(e)</span> A procedure for the disposing and destruction of containers, labels, and packaging to ensure that the containers, labels, and packaging cannot be used in counterfeiting activities, including all necessary documentation, maintained for a minimum of 3 years, and the appropriate witnessing of the destruction of any labels, packaging, immediate containers, or containers in accordance with applicable federal and State requirements; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)(f)">(f)</span> A procedure for identifying, segregating, investigating, and reporting prescription drug inventory discrepancies involving counterfeit, suspect of being counterfeit, contraband, or suspect of being contraband, in the inventory and reporting of such discrepancies within 5 business days to the Board and appropriate federal or State agency upon discovery of such discrepancies.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(3)">(3)</span> If deviation is appropriate, a wholesale distributor may temporarily deviate from the requirement in <a class="internal-link " href="/us/md/exec/comar/10.34.22.07#B(2)(a)" title="">§B(2)(a) of this regulation</a> that the oldest approved and unexpired stock be distributed first.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(4)">(4)</span> The wholesale distributor shall maintain documentation of the disposition of outdated prescription drugs or devices for 2 years after the disposition of the outdated prescription drugs or devices pursuant to procedures under <a class="internal-link " href="/us/md/exec/comar/10.34.22.07#B(2)(d)" title="">§B(2)(d) of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#C">C.</span> Responsible Individuals. A wholesale distributor shall establish and maintain a list of officers, directors, managers, the designated representative, and others in charge of wholesale distribution, storage, and handling, including:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#C(1)">(1)</span> A description of their duties; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#C(2)">(2)</span> A summary of their qualifications.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#D">D.</span> Compliance with Federal, State, and Local Law. A wholesale distributor shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#D(1)">(1)</span> Operate in compliance with applicable federal, State, and local laws and regulations;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#D(2)">(2)</span> Permit at reasonable times and in a reasonable manner, the Board, the State Division of Drug Control, and any other authorized federal, State, and local law enforcement officials showing proper identification to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#D(2)(a)">(a)</span> Enter and inspect the distributor's premises and delivery vehicles; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#D(2)(b)">(b)</span> Audit and copy the distributor's records and written operating procedures; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#D(3)">(3)</span> If dealing in controlled substances:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#D(3)(a)">(a)</span> Register with the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#D(3)(a)(i)">(i)</span> Maryland Division of Drug Control; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#D(3)(a)(ii)">(ii)</span> United States Drug Enforcement Administration; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#D(3)(b)">(b)</span> Comply with all applicable federal, State, and local regulations.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#E">E.</span> Salvaging and Reprocessing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#E(1)">(1)</span> A wholesale distributor is subject to the provisions of applicable federal, State, or local laws or regulations that relate to prescription drug product salvaging or reprocessing, including 21 CFR Parts 207, 210, and 211, as amended.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#E(2)">(2)</span> A wholesale distributor is subject to the provisions of any applicable federal, State, or local laws or regulations that relate to prescription device product salvaging or reprocessing.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.22.08" data-order="|10|34|22|.08|" data-ref-path="10|34|22|.08" class="h__section">.08 Due Diligence.</h2>
                <p>Wholesale distributors having transactions with persons not licensed by the Board or not certified by a third party recognized by the Board shall have in place policies and procedures to perform due diligence on transactions that take place that include:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.08#A">A.</span> Verification of alternate licensure;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.08#B">B.</span> Verification of identity; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.08#C">C.</span> Verification of recent inspections by a state or third party entity recognized by the Board.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.22.09" data-order="|10|34|22|.09|" data-ref-path="10|34|22|.09" class="h__section">.09 Reinstatement.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.09#A">A.</span> The wholesale distributor permit shall expire on the last day of its term.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.09#B">B.</span> The Board may not reinstate the wholesale distributor permit unless the applicant pays a reinstatement fee set by the Board.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.22.10" data-order="|10|34|22|.10|" data-ref-path="10|34|22|.10" class="h__section">.10 Required Information and Procedures for Ceasing to Operate.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#A">A.</span> If a wholesale distributor is located in another state, a wholesale distributor anticipating ceasing to operate in Maryland shall return the permit to the Board within 10 days of ceasing to operate in Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B">B.</span> Procedures for Wholesale Distributors Located in this State for Ceasing to Operate.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(1)">(1)</span> Notification.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(1)(a)">(a)</span> At least 30 days before a wholesale distributor’s anticipated date of ceasing to operate, the wholesale distributor shall notify the Board in writing, by certified mail, return receipt requested, or hand delivered to the Board’s office, of the day on which the wholesale distributor will cease to operate.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(1)(b)">(b)</span> A wholesale distributor shall:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(1)(b)(i)">(i)</span> Notify drug and device suppliers that supply prescription drugs and devices to the wholesale distributor, at least 30 days in advance of ceasing to operate, of the date that the wholesale distributor will cease to operate;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(1)(b)(ii)">(ii)</span> Notify manufacturers, wholesale distributors, licensed pharmacies and authorized prescribers that receive prescription drugs and devices from the wholesale distributor, at least 30 days in advance of ceasing to operate, of the date that the wholesale distributor will cease to operate; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(1)(b)(iii)">(iii)</span> Comply with applicable federal regulations.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(2)">(2)</span> The wholesale distributor shall submit to and pass a closing inspection conducted by the Board.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(3)">(3)</span> With the exception of controlled dangerous substances, the wholesale distributor shall dispose of prescription drugs or devices in stock by one or more of the following means:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(3)(a)">(a)</span> Returning the prescription drugs or devices to a distributor or manufacturer;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(3)(b)">(b)</span> Transferring the prescription drugs or devices to another wholesale distributor, licensed pharmacy, authorized prescriber, or other person or entity approved by the Board; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(3)(c)">(c)</span> Destroying in accordance with this regulation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(4)">(4)</span> Disposition of Controlled Dangerous Substances. The wholesale distributor shall comply with the procedures set forth in this regulation in addition to those set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.19.03.10" title=".10 Records and Reports Required of Registrants.">COMAR 10.19.03.10</a> governing the transfer, return or disposal of controlled dangerous substances.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(5)">(5)</span> At the closing inspection, the wholesale distributor shall provide to the Board the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(5)(a)">(a)</span> The exact date on which the wholesale distributor ceased to operate;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(5)(b)">(b)</span> A copy of the inventory of prescription drugs or devices disposed of, transferred, or returned.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(5)(c)">(c)</span> The names, addresses, telephone numbers, and Drug Enforcement Administration registration numbers, if applicable, of the persons or business entities to whom prescription drugs or devices in stock were returned or transferred under this regulation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(5)(d)">(d)</span> The wholesale distributor permit;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(5)(e)">(e)</span> If prescription drugs or devices are destroyed pursuant to this regulation, a letter, signed under oath by the wholesale distributor, stating the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(5)(e)(i)">(i)</span> Date, place and manner in which the prescription drugs or devices were destroyed;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(5)(e)(ii)">(ii)</span> Names, addresses, and telephone numbers of the persons responsible for destroying the prescription drugs or devices; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(5)(e)(iii)">(iii)</span> Name, dosage unit, and quantity of each type of prescription drug or device destroyed; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(5)(f)">(f)</span> If any pedigrees or other documents are transferred, a letter, signed under oath by the wholesale distributor, stating:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(5)(f)(i)">(i)</span> The date, time, place to which and manner in which the pedigrees or other documents were transferred; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(5)(f)(ii)">(ii)</span> The names, addresses, and telephone numbers of the persons responsible for transferring the pedigrees or other documents.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(6)">(6)</span> At the closing inspection, the wholesale distributor shall provide to the Division of Drug Control the following pertaining to controlled dangerous substances:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(6)(a)">(a)</span> The exact date on which the wholesale distributor ceased to operate;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(6)(b)">(b)</span> A copy of the closing inventory of controlled dangerous substances required by the Drug Enforcement Administration.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(6)(c)">(c)</span> The names, addresses, telephone numbers, Drug Enforcement Administration registration numbers, Division of Drug Control registration numbers, and Board permit numbers, if applicable, of the persons or business entities to whom controlled dangerous substances in stock were returned or transferred under this regulation; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(6)(d)">(d)</span> The Maryland Department of Health Controlled Dangerous Substance Registration for cancellation.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.22.11" data-order="|10|34|22|.11|" data-ref-path="10|34|22|.11" class="h__section">.11 Relocation.</h2>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.11#A">A.</span> At least 30 days before relocation, a permit holder shall submit an application to the Board.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.11#B">B.</span> If relocation is due to a catastrophic event or State of Emergency, the relocation applicant shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.11#B(1)">(1)</span> Notify the Board within 48 hours; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.11#B(2)">(2)</span> Submit an application to the Board within 30 days.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.11#C">C.</span> A relocation applicant:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.11#C(1)">(1)</span> If the applicant holds products, shall comply with <a class="internal-link " href="/us/md/exec/comar/10.34.22.07" title=".07 Minimum Requirements for Maintenance of Prescription Drug or Device Distribution Records.">Regulation .07 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.11#C(2)">(2)</span> Shall submit a surety bond or other equivalent means of security acceptable to the State specific to the permit holder’s relocation, in accordance with Regulation .03 if this chapter; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.11#C(3)">(3)</span> Shall indicate on the application changes in product or personnel from the original application to the Board.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.11#D">D.</span> A new or different designated representative or immediate supervisor of a designated representative functioning at the relocated facility shall be required to undergo a criminal history records check as set forth in <a class="internal-link " href="/us/md/exec/comar/10.34.22.03" title=".03 Minimum Application Requirements for Applicants Holding Product.">Regulation .03 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.11#E">E.</span> As part of the application process, a relocation applicant located in this State shall submit to and pass an opening inspection conducted by the Board, which shall include:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.11#E(1)">(1)</span> Documentation of the permit holder’s notification to suppliers of prescription drugs and devices of the permit holder’s relocation; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.11#E(2)">(2)</span> Documentation from the permit holder evidencing the appropriate transfer, return, or disposal of any prescription drugs or devices not transferred to the facility’s relocation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.11#F">F.</span> A relocation applicant located in another state shall provide to the Board:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.11#F(1)">(1)</span> Evidence of approval of the permit holder’s relocation from the accreditation organization that accredited the permit holder’s original location; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.11#F(2)">(2)</span> If the relocation applicant is not required to be accredited by an accreditation organization in accordance with Maryland law, inspection reports from the state in which the relocation applicant is located pertaining to the permit holder’s relocation.</p>
                <hr class="section-separator" aria-hidden="true"/>
              </div>
            </article>
          </main>
          <nav id="area__navigation_mini" class="ns__document__maryland-dsd" aria-label="Previous and next article links">
            <section>
              <a href="/us/md/exec/comar/10.34.21" aria-label="Chapter 21 Standard of Practice for Unlicensed Personnel">
                <div class="h__ui">Previous</div>
                <span>Chapter 21 Standard of Practice for Unlicensed Personnel</span>
              </a>
            </section>
            <section>
              <a href="/us/md/exec/comar/10.34.23" aria-label="Chapter 23 Pharmaceutical Services to Patients in Comprehensive Care Facilities">
                <div class="h__ui">Next</div>
                <span>Chapter 23 Pharmaceutical Services to Patients in Comprehensive Care Facilities</span>
              </a>
            </section>
          </nav>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__maryland-dsd">
        <div id="section__footer__inner" class="ns__document__maryland-dsd">
          <div id="area__footer__content" class="ns__document__maryland-dsd">
<p>This version of the laws and codes on this website is licensed under the <a href="https://creativecommons.org/licenses/by-nc-sa/4.0/">CC BY-NC-SA 4.0</a> license with copyright held by the State of Maryland.</p><p>This version of the laws and codes on this website will be dedicated to the public domain under the <a href="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0</a> license 180 days after publication.</p>
<p>
      Please do not scrape. Instead, bulk download the CC BY-NC-SA-4.0 <a href="https://github.com/maryland-dsd/law-html">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml">XML</a> or CC0 <a href="https://github.com/maryland-dsd/law-html-cc0">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml-cc0">XML</a>.
    </p><p>Powered by the non-profit <a href="https://www.openlawlib.org/">Open Law Library</a>.</p></div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
